Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Teva to Acquire Ratiopharm in Deal Valued Near $5 Billion
March 19, 2010
Teva Pharmaceutical Industries Ltd. won the bidding for generic-drug manufacturer
Ratiopharm, agreeing to buy the German firm in a deal valued at 3.63 billion euros ($4.97 billion).
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing